Continue to Innovate Services, Therapies and Products

Next Gen IGIV

2002 Key Products

2005+

2003-2005

Endobulin S/D

Gammagard S/D

SubQ IG

New Delivery Methods

Therapy Opportunity

IGIV Portfolio

• Intravenous immunoglobulin

• Lyophilized

• Continue to develop new indications

• Intravenous immunoglobulin

• Lyophilized

• Higher concentration (10%)

• Liquid formulation

• Three viral inactivation steps

• Higher yields

• New method of delivery subcutaneous

• More convenient patient administration

Previous slide

Next slide

Back to first slide

View graphic version